ATPW
BSX icon

Ashton Thomas Private Wealth’s Boston Scientific BSX Stock Holding History

Ashton Thomas Private Wealth’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$213K Sell
4,983
-5,899
-54% -$320K ﹤0.01% 1127
2026
Q1 		$683K Sell
10,882
-177
-2% -$14.2K 0.02% 644
2025
Q4 		$1.05M Sell
11,059
-2,375
-18% -$233K 0.03% 481
2025
Q3 		$1.31M Buy
13,434
+1,827
+16% +$189K 0.03% 405
2025
Q2 		$1.25M Buy
11,607
+4,966
+75% +$502K 0.04% 363
2025
Q1 		$670K Buy
6,641
+696
+12% +$70.1K 0.03% 481
2024
Q4 		$531K Buy
5,945
+136
+2% +$12K 0.02% 521
2024
Q3 		$487K Sell
5,809
-107
-2% -$8.44K 0.03% 443
2024
Q2 		$456K Buy
5,916
+128
+2% +$9.37K 0.02% 441
2024
Q1 		$396K Buy
5,788
+475
+9% +$30.5K 0.02% 458
2023
Q4 		$307K Hold
5,313
– – 0.02% 493
2023
Q3 		$281K Buy
5,313
+101
+2% +$5.3K 0.02% 482
2023
Q2 		$282K Buy
+5,212
New +$272K 0.02% 490

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ashton Thomas Private Wealth's BSX Position: Q2 2026 in Review

Ashton Thomas Private Wealth reduced its Boston Scientific (BSX) stake by 54% in Q2 2026, selling an estimated $320K and leaving 4,983 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #1127.

Ashton Thomas Private Wealth first reported a position in BSX in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.31M in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Ashton Thomas Private Wealth held 4,983 shares of Boston Scientific worth $213K as of Q2 2026.
  • Ashton Thomas Private Wealth sold 5,899 Boston Scientific shares in Q2 2026, an estimated $320K.
  • Boston Scientific made up ﹤0.01% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #1127 holding.
  • Ashton Thomas Private Wealth first reported a position in Boston Scientific in Q2 2023 and has held it in 13 quarters since.
  • Ashton Thomas Private Wealth's Boston Scientific position peaked at $1.31M in Q3 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.